The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CNS activity of poziotinib in NSCLC with exon 20 insertion mutations.
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; EMD Serono; Lilly; Spectrum Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Lilly (Inst)
 
Marina Chiara Garassino
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; MSD Oncology; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Daiiki Sankyo; GlaxoSmithKline; Incyte; Inivata; Janssen; Lilly; MSD; Novartis; Pfizer; Regeneron; Roche; Sanofi; Seagen; Takeda; Tiziana Life Sciences
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Incyte; Lilly; MSD Oncology; Otsuka; Roche; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Robin Cornelissen
Honoraria - Boehringer Ingelheim; Pfizer; Roche; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals
Consulting or Advisory Role - MSD
 
Mark A. Socinski
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Lilly; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech; Janssen; Lilly; Novartis
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Merck
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Spectrum Pharmaceuticals (Inst)
 
Nishan Tchekmedyian
No Relationships to Disclose
 
Julian R. Molina
No Relationships to Disclose
 
Christina S Baik
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Daiichi; NCCN; Takeda
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Novartis (Inst); Pfizer (Inst); Rain Therapeutics (Inst); Spectrum Pharmaceuticals (Inst); Spectrum Pharmaceuticals (Inst); TP Therapeutics (Inst)
 
Sharon Leu
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
 
Lyndah Dreiling
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
 
Francois M. Lebel
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
 
Jeffrey Melson Clarke
Honoraria - AstraZeneca; Genentech; Merck; NGM Biopharmaceuticals; Pfizer; Spectrum Pharmaceuticals; Spectrum Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Genentech; Guardant Health; Merck; NGM Biopharmaceuticals; Pfizer; Spectrum Pharmaceuticals
Speakers' Bureau - AstraZeneca; Merck
Research Funding - Abbvie; Achilles Therapeutics; Adaptimmune; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Grid Therapeutics; Moderna Therapeutics; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Merck; NGM Biopharmaceuticals; Pfizer
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina